Latest Misonix Inc (MSON) Headlines Wound Debri
Post# of 21
Posted On: 03/13/2014 11:22:54 AM
Latest Misonix Inc (MSON) Headlines
Wound Debridement Products - Global Strategic Business Report
M2 - Wed Mar 12, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ffjwkx/wound_debridement) has announced the addition of the "Wound Debridement Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 35 companies including many key and niche players such as: - Advanced Medical Solutions Group plc - ArthroCare Corporation - Coloplast A/S - Derma Sciences, Inc. - Misonix, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends And Issues 3. Product Overview 4. Strategic Corporate Developments 5. Focus On Select Global Players 6. Global Market Perspective III. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/ff...ebridement About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Misonix Shares Up 25.5% Since SmarTrend's Buy Recommendation (MSON)
Comtex SmarTrend(R) - Mon Mar 10, 9:15AM CDT
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on November 26th, 2013 at $5.34. In approximately 3 months, Misonix has returned 25.47% as of today's recent price of $6.70.
Misonix Exhibits At The 65th Southern Neurosurgical Society Annual Conference And Offers Extensive "Hands-On" BoneScalpel(TM) and SonaStar® Product Demonstrations
PR Newswire - Thu Mar 06, 1:47PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, recently attended the 65th Southern Neurosurgical Society (SNS) Annual Meeting in San Juan, Puerto Rico from February 19-22, 2014.
Misonix Reports More Than 200 Podiatry Professionals Trial the SonicOne® O.R.
PR Newswire - Mon Mar 03, 1:18PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, recently attended the 72nd Annual Scientific Conference of the American College of Foot and Ankle Surgeons where more than 200 podiatric professionals engaged in "hands-on" trials of Misonix's SonicOne O.R. Ultrasonic Surgical Debridement System. The conference took place at the Gaylord Palms Convention Center in Kissimmee, Florida from February 27, through March 1, 2014.
A MICHAEL. MCMANUS JR of Misonix Inc. (MSON)-NasdaqGM bought Shares of MSON
M2 - Mon Feb 24, 8:17AM CST
Reported by InsiderCow.com at 2014-02-21 14:08:57
Shares of MSON Up 22.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Feb 14, 9:44AM CST
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on November 26th, 2013 at $5.34. In approximately 3 months, Misonix has returned 22.85% as of today's recent price of $6.56.
33.5% Return Seen to Date on SmarTrend Misonix Call (MSON)
Comtex SmarTrend(R) - Fri Feb 07, 9:21AM CST
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on November 26th, 2013 at $5.34. In approximately 2 months, Misonix has returned 33.52% as of today's recent price of $7.13.
Nasdaq stocks posting largest volume increases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Misonix, Inc. Announces Second Quarter Fiscal Year 2014 Financial Results
PR Newswire - Wed Feb 05, 3:01PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the second quarter of fiscal year 2014 and six months ended December 31, 2013.
Misonix, Inc. To Report Second Quarter 2014 Financial Results On Wednesday, February 5, 2014
PR Newswire - Fri Jan 31, 11:02AM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that it will report financial results for the second quarter of fiscal year 2014 ended December 31, 2013 on Wednesday, February 5, 2014. The Company has scheduled a conference call that same day, Wednesday, February 5, 2014, at 4:30 pm ET to review the results.
Misonix, Inc. Enhances its Web Presence with the Unveiling of its New Website
PR Newswire - Fri Jan 31, 6:30AM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, launched its new corporate website on January 27, 2014.
Poster Featuring Misonix BoneScalpel(TM) Wins Best in Show Award at 62nd Neurological Society of India Annual Conference
PR Newswire - Thu Jan 30, 6:30AM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced that a scientific poster titled "BoneScalpel - A cutting edge technology" won the Best Poster Award at the 62nd Annual Conference of the Neurological Society of India (NSICON) in Mumbai held December 11-15, 2013.
Misonix Exhibits at the Annual New York Podiatric Clinical Conference and Offers "Hands-On" SonicOne® O.R. System Trials
PR Newswire - Wed Jan 29, 3:50PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, recently attended the 2014 New York State Podiatric Clinical Conference held at the Marriott Marquis in New York City, NY from January 24th - 26th, 2014.
G-SHOCK Debuts A New Series Of WINTER G-LIDE - GLS-8900 Just In Time For The Winter Games
PR Newswire - Wed Jan 29, 11:53AM CST
Casio G-SHOCK is back with an impressive assortment of the WINTER G-LIDE GLS8900 series. Emphasizing superior functionality and performance, the recent G-LIDE collection is designed for athletes specializing in winter sports including snowboarding, cross-country and freestyle skiing.
Wound Debridement Products - Global Strategic Business Report
M2 - Wed Mar 12, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ffjwkx/wound_debridement) has announced the addition of the "Wound Debridement Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 35 companies including many key and niche players such as: - Advanced Medical Solutions Group plc - ArthroCare Corporation - Coloplast A/S - Derma Sciences, Inc. - Misonix, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends And Issues 3. Product Overview 4. Strategic Corporate Developments 5. Focus On Select Global Players 6. Global Market Perspective III. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/ff...ebridement About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Misonix Shares Up 25.5% Since SmarTrend's Buy Recommendation (MSON)
Comtex SmarTrend(R) - Mon Mar 10, 9:15AM CDT
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on November 26th, 2013 at $5.34. In approximately 3 months, Misonix has returned 25.47% as of today's recent price of $6.70.
Misonix Exhibits At The 65th Southern Neurosurgical Society Annual Conference And Offers Extensive "Hands-On" BoneScalpel(TM) and SonaStar® Product Demonstrations
PR Newswire - Thu Mar 06, 1:47PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, recently attended the 65th Southern Neurosurgical Society (SNS) Annual Meeting in San Juan, Puerto Rico from February 19-22, 2014.
Misonix Reports More Than 200 Podiatry Professionals Trial the SonicOne® O.R.
PR Newswire - Mon Mar 03, 1:18PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, recently attended the 72nd Annual Scientific Conference of the American College of Foot and Ankle Surgeons where more than 200 podiatric professionals engaged in "hands-on" trials of Misonix's SonicOne O.R. Ultrasonic Surgical Debridement System. The conference took place at the Gaylord Palms Convention Center in Kissimmee, Florida from February 27, through March 1, 2014.
A MICHAEL. MCMANUS JR of Misonix Inc. (MSON)-NasdaqGM bought Shares of MSON
M2 - Mon Feb 24, 8:17AM CST
Reported by InsiderCow.com at 2014-02-21 14:08:57
Shares of MSON Up 22.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Feb 14, 9:44AM CST
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on November 26th, 2013 at $5.34. In approximately 3 months, Misonix has returned 22.85% as of today's recent price of $6.56.
33.5% Return Seen to Date on SmarTrend Misonix Call (MSON)
Comtex SmarTrend(R) - Fri Feb 07, 9:21AM CST
SmarTrend identified an Uptrend for Misonix (NASDAQ:MSON) on November 26th, 2013 at $5.34. In approximately 2 months, Misonix has returned 33.52% as of today's recent price of $7.13.
Nasdaq stocks posting largest volume increases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Misonix, Inc. Announces Second Quarter Fiscal Year 2014 Financial Results
PR Newswire - Wed Feb 05, 3:01PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the second quarter of fiscal year 2014 and six months ended December 31, 2013.
Misonix, Inc. To Report Second Quarter 2014 Financial Results On Wednesday, February 5, 2014
PR Newswire - Fri Jan 31, 11:02AM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that it will report financial results for the second quarter of fiscal year 2014 ended December 31, 2013 on Wednesday, February 5, 2014. The Company has scheduled a conference call that same day, Wednesday, February 5, 2014, at 4:30 pm ET to review the results.
Misonix, Inc. Enhances its Web Presence with the Unveiling of its New Website
PR Newswire - Fri Jan 31, 6:30AM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, launched its new corporate website on January 27, 2014.
Poster Featuring Misonix BoneScalpel(TM) Wins Best in Show Award at 62nd Neurological Society of India Annual Conference
PR Newswire - Thu Jan 30, 6:30AM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced that a scientific poster titled "BoneScalpel - A cutting edge technology" won the Best Poster Award at the 62nd Annual Conference of the Neurological Society of India (NSICON) in Mumbai held December 11-15, 2013.
Misonix Exhibits at the Annual New York Podiatric Clinical Conference and Offers "Hands-On" SonicOne® O.R. System Trials
PR Newswire - Wed Jan 29, 3:50PM CST
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, recently attended the 2014 New York State Podiatric Clinical Conference held at the Marriott Marquis in New York City, NY from January 24th - 26th, 2014.
G-SHOCK Debuts A New Series Of WINTER G-LIDE - GLS-8900 Just In Time For The Winter Games
PR Newswire - Wed Jan 29, 11:53AM CST
Casio G-SHOCK is back with an impressive assortment of the WINTER G-LIDE GLS8900 series. Emphasizing superior functionality and performance, the recent G-LIDE collection is designed for athletes specializing in winter sports including snowboarding, cross-country and freestyle skiing.
(0)
(0)Misonix Inc. (MSON) Stock Research Links
Scroll down for more posts ▼